116 related articles for article (PubMed ID: 6610522)
1. Fluoxetine kinetics and protein binding in normal and impaired renal function.
Aronoff GR; Bergstrom RF; Pottratz ST; Sloan RS; Wolen RL; Lemberger L
Clin Pharmacol Ther; 1984 Jul; 36(1):138-44. PubMed ID: 6610522
[TBL] [Abstract][Full Text] [Related]
2. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
Orsulak PJ; Kenney JT; Debus JR; Crowley G; Wittman PD
Clin Chem; 1988 Sep; 34(9):1875-8. PubMed ID: 3262022
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine: clinical pharmacology and physiologic disposition.
Lemberger L; Bergstrom RF; Wolen RL; Farid NA; Enas GG; Aronoff GR
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):14-9. PubMed ID: 3871765
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine disposition and elimination in cirrhosis.
Schenker S; Bergstrom RF; Wolen RL; Lemberger L
Clin Pharmacol Ther; 1988 Sep; 44(3):353-9. PubMed ID: 3262026
[TBL] [Abstract][Full Text] [Related]
5. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
[TBL] [Abstract][Full Text] [Related]
6. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.
Caccia S; Cappi M; Fracasso C; Garattini S
Psychopharmacology (Berl); 1990; 100(4):509-14. PubMed ID: 2320712
[TBL] [Abstract][Full Text] [Related]
7. Rapid and direct measurement of free concentrations of highly protein-bound fluoxetine and its metabolite norfluoxetine in plasma.
Guo B; Li C; Wang G; Chen L
Rapid Commun Mass Spectrom; 2006; 20(1):39-47. PubMed ID: 16308873
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics, disposition and metabolism of fluoxetine in crabs.
Robert A; Schultz IR; Hucher N; Monsinjon T; Knigge T
Chemosphere; 2017 Nov; 186():958-967. PubMed ID: 28830067
[TBL] [Abstract][Full Text] [Related]
9. Serum fluoxetine and norfluoxetine concentrations and antidepressant response.
Kelly MW; Perry PJ; Holstad SG; Garvey MJ
Ther Drug Monit; 1989; 11(2):165-70. PubMed ID: 2785723
[TBL] [Abstract][Full Text] [Related]
10. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac).
Pohland RC; Bernhard NR
J Forensic Sci; 1997 Sep; 42(5):812-6. PubMed ID: 9304827
[TBL] [Abstract][Full Text] [Related]
11. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
Bergstrom RF; Beasley CM; Levy NB; Blumenfield M; Lemberger L
Int Clin Psychopharmacol; 1993; 8(4):261-6. PubMed ID: 8277145
[TBL] [Abstract][Full Text] [Related]
12. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection.
Nash JF; Bopp RJ; Carmichael RH; Farid KZ; Lemberger L
Clin Chem; 1982 Oct; 28(10):2100-2. PubMed ID: 6982125
[TBL] [Abstract][Full Text] [Related]
13. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
Keck PE; McElroy SL
J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing.
Burke WJ; Hendricks SE; McArthur-Campbell D; Jacques D; Stull T
Psychopharmacol Bull; 1996; 32(1):27-32. PubMed ID: 8927671
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation.
Heikkinen T; Ekblad U; Palo P; Laine K
Clin Pharmacol Ther; 2003 Apr; 73(4):330-7. PubMed ID: 12709723
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
[TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.
Ciribassi J; Luescher A; Pasloske KS; Robertson-Plouch C; Zimmerman A; Kaloostian-Whittymore L
Am J Vet Res; 2003 Aug; 64(8):994-8. PubMed ID: 12926591
[TBL] [Abstract][Full Text] [Related]
18. Red cell and plasma concentrations of fluoxetine and norfluoxetine.
Amitai Y; Kennedy E; DeSandre P; Fawcett J; Frischer H
Vet Hum Toxicol; 1993 Apr; 35(2):134-6. PubMed ID: 8470355
[TBL] [Abstract][Full Text] [Related]
19. An
Chow TW; Nguyen TA; Riggs KW; Rurak DW
Xenobiotica; 2019 Nov; 49(11):1360-1372. PubMed ID: 30587071
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine.
Wright CE; Lasher-Sisson TA; Steenwyk RC; Swanson CN
Pharmacotherapy; 1992; 12(2):103-6. PubMed ID: 1570226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
